Voyager Therapeutics Inc.
VYGR | NASDAQ
$3.12
+$0.04 (+1.30%)
Sep 22, 2026, 1:35 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -135.67M | -116.64M | -119.72M | -126.78M | -107.93M | -84.69M | -65M | 25.88M | 9.02M | -3.04M | 132.33M | 52.31M | 95.83M | 98.96M | -46.41M | -17.07M | -59.83M | -70.87M | -71.2M | -92.83M | 17.92M | 39.36M |
Depreciation & Amortization | 4.39M | 3.61M | 4.06M | 4.02M | 4.22M | 4.55M | 4.73M | 5.06M | 4.87M | 4.56M | 4.44M | 3.94M | 4.34M | 4.45M | 6.19M | 6.84M | 6.72M | 6.7M | 5.17M | 4.67M | 4.51M | 4.25M |
Stock-Based Compensation | 14.39M | 13.6M | 14.79M | 15M | 14.98M | 14.89M | 14.79M | 14.09M | 13.54M | 12.17M | 11.15M | 10.45M | 9.77M | 9.58M | 9.34M | 8.65M | 8.54M | 10.04M | 11.32M | 9.67M | 7.59M | 7.46M |
Other Working Capital | -36.55M | -27.31M | -30.05M | -19.72M | -19.78M | -39.5M | -48.84M | -48.08M | -43.29M | -23.2M | 16.46M | 13.96M | -12.46M | -11.64M | 18M | 23.29M | 51.29M | 52.56M | -3.93M | -10.66M | -126.8M | -146.77M |
Other Non-Cash Items | 2.21M | -1.82M | -2.83M | -3.85M | -5.06M | -3.62M | -4.68M | -4.96M | -4.88M | -4.29M | -3.45M | -1.31M | 458K | 388K | 382K | 23K | 159K | 1.69M | -2.11M | -6.27M | -3.62M | -5.1M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 66K |
Change in Working Capital | -39.32M | -26.75M | -28.76M | -5.13M | -19.86M | -43.1M | 34.86M | -64.61M | -40.17M | 3.73M | -66.56M | 24.04M | -16.11M | -34.26M | 20.47M | 14.98M | 53.33M | 54.63M | 3.29M | -1.93M | -117.13M | -135.24M |
Operating Cash Flow | -153.99M | -127.99M | -132.47M | -116.73M | -113.65M | -111.97M | -15.31M | -24.54M | -17.62M | 13.12M | 77.92M | 89.44M | 94.28M | 76.63M | -12.51M | 10.93M | 6.43M | 2.2M | -53.53M | -86.7M | -90.73M | -89.21M |
Capital Expenditures | -861K | -1.95M | -2.6M | -2.13M | -2.18M | -2.04M | -3.52M | -4.12M | -4.65M | -4.89M | -3.26M | -3.43M | -2.93M | -2.96M | -2.49M | -1.91M | -2.29M | -1.27M | -1.61M | -4.82M | -9.31M | -10.97M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 157.52M | 180.98M | 180.98M | 180.98M | 23.45M | n/a | n/a | n/a | n/a | n/a | n/a | -31K | -31K | -31K |
Purchase of Investments | -133.43M | -100.45M | -133.93M | -252.44M | -286.62M | -338.76M | -465.69M | -363.66M | -489.37M | -427.82M | -223.97M | -194.98M | -28.45M | -34.89M | -54.85M | -69.97M | -69.97M | -35.08M | -15.12M | -45.42M | -55.42M | -70.4M |
Sales Maturities Of Investments | 248.2M | 194.74M | 261.97M | 305.39M | 369.08M | 383.2M | 374.35M | 326.96M | 230.54M | 180.51M | 85.58M | 44M | 70M | 65M | 50M | 45M | 25M | 47.63M | 82.63M | 100.13M | 127.63M | 120M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -157.52M | -180.98M | -180.98M | -180.98M | -23.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31K |
Investing Cash Flow | 113.91M | 92.35M | 125.45M | 50.82M | 80.28M | 42.41M | -94.86M | -40.82M | -263.48M | -252.2M | -141.64M | -154.41M | 38.62M | 27.15M | -7.34M | -26.87M | -47.25M | 11.28M | 65.91M | 49.85M | 62.87M | 38.63M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 571K | 649K | 1.11M | 1.44M | 2.42M | 2.52M | 2.34M | 2.02M | 1.28M | 1.11M | 1.06M | 1.05M | 596K | 612K | 871K | 1.38M | 3.16M |
Financial Cash Flow | 9.79M | 4.07M | 816K | 1.25M | 1.18M | 1.24M | 114.02M | 113.9M | 114.22M | 115.2M | 33.65M | 33.46M | 33.15M | 32.4M | 1.11M | 1.06M | 1.05M | 596K | 612K | 871K | 1.38M | 3.16M |
Net Cash Flow | -33.04M | -34.32M | -8.95M | -67.4M | -32.19M | -68.32M | 3.85M | 48.54M | -166.89M | -123.88M | -30.08M | -31.51M | 166.04M | 136.45M | -18.47M | -14.62M | -39.52M | 14.07M | 12.99M | -35.97M | -26.48M | -47.43M |
Free Cash Flow | -154.85M | -129.94M | -135.06M | -118.86M | -115.83M | -114.01M | -18.83M | -28.66M | -22.27M | 8.23M | 74.66M | 86M | 91.35M | 73.67M | -15M | 9.02M | 4.14M | 923K | -55.13M | -91.52M | -100.04M | -100.18M |
Adj. Free Cash Flow | -169.24M | -143.55M | -149.85M | -133.86M | -130.81M | -128.9M | -33.62M | -42.76M | -35.81M | -3.94M | 63.51M | 75.55M | 81.59M | 64.08M | -24.35M | 372K | -4.4M | -9.12M | -66.46M | -101.19M | -107.63M | -107.64M |
Maintenance CapEx | -235K | -1.33M | -1.97M | -2.13M | -1.92M | -813K | -2.3M | -2.14M | -2.92M | -2.92M | -782K | -1.72M | -933K | -2.18M | -2.21M | -1.28M | -1.94M | -925K | -1.26M | -4.82M | -4.16M | -5.81M |
Growth CapEx | -626K | -626K | -626K | n/a | -258K | -1.23M | -1.23M | -1.98M | -1.72M | -1.97M | -2.47M | -1.72M | -2M | -787K | -278K | -625K | -347K | -347K | -347K | n/a | -5.15M | -5.15M |
Owner Earnings | -154.23M | -129.32M | -134.44M | -118.86M | -115.57M | -112.79M | -17.61M | -26.68M | -20.55M | 10.2M | 77.14M | 87.72M | 93.35M | 74.45M | -14.72M | 9.65M | 4.49M | 1.27M | -54.79M | -91.52M | -94.89M | -95.03M |
Add to Watchlist
Select watchlists to add or remove VYGR